FdaApplication

ANDA 203078

Back to search

Identifiers

Properties

PropertyValue
applicant_nameHIKMA PHARMACEUTICALS USA INC
application_typeANDA
approval_date2022-06-28

Products (2)

ProductActive ingredientStrengthDosage form
CISATRACURIUM BESYLATECISATRACURIUM BESYLATEEQ 2MG BASE/MLINJECTABLE;INJECTION
CISATRACURIUM BESYLATECISATRACURIUM BESYLATEEQ 10MG BASE/MLINJECTABLE;INJECTION

2 products